91´«Ã½

The was established in 2003 to build on Stanford's leadership in stem cell science and to set the foundations for the creation of a new field of science: regenerative medicine. Under the direction of renowned stem cell researcher Dr. Irving Weissman, the institute is devoted to exploring the how stem cells are created, the mechanisms by which they are regulated and how they devolve into specialized cells.

Stem cell research at focuses on the basic biological systems operating in the processes of self-renewal and differentiation of stem cells.

Stem cells hold great promise for curing or mitigating the effects of many diseases and injuries. But before a single clinical trial can commence, basic research must take place to uncover the pathways, mechanisms, and cellular effects of potential stem-cell-based cures. Basic research is also needed to overcome technological hurdles, such as how to ensure that stem cells work effectively when injected into a living organism. Investment in basic research of the kind done at the IBSC is an essential step toward stem-cell-based cures.

The Center for Biomolecular Science & Engineering administers the UCSC Institute for the Biology of Stem Cells.

The Eli and Edythe of Regeneration Medicine and Stem Cell Research is one of the largest and most comprehensive programs of its kind. Our mission is to combine yesterday's discoveries to create tomorrow's breakthroughs and shape the future of medicine.

Physicians and scientists collaborate to discover the inner workings of stem cells, engineer new treatments using powerful genome editing tools, and ultimately heal patients by developing life-saving therapies. By harnessing the power of stem cells, the building blocks of all human tissues, we can treat and even cure diseases that affect systems throughout the body. Our scientists are redesigning cell-delivery and genome-editing tools to make them both more precise and more customizable, improving the effectiveness and safety of stem cell therapies.

For 75 years, has led the discovery and design of ground-breaking products, technologies and industries – collaborating across technical and scientific disciplines to generate real innovation and create high value for our clients.

is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.

Bridging the drug discovery path with translatable neuroscience. is an innovative biotechnology company focused on CNS drug discovery.

is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

is modernizing drug discovery. Their mission is to replace, reduce and refine the use of monkeys in boimedical research.